Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Hoyer

Showing results (11-20 of 151) with videos related to

Pageof 16
Sort By:
Drug Discovery Today. Therapeutic Strategies|April 15, 2020
RNA interference as a therapeutic strategy for treating CNS disordersDaniel Hoyer, Kumlesh K Dev
Science (New York, N.Y.)|February 24, 2022
Losing sleep with ageLaura H Jacobson, Daniel Hoyer
Neuropeptides|November 13, 2013
Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?Daniel Hoyer, Laura H Jacobson
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 17, 2003
Native somatostatin sst2 and sst5 receptors functionally coupled to Gi/o-protein, but not to the serum response element in AtT-20 mouse tumour corticotrophsDavide Cervia, Dominique Fehlmann, Daniel Hoyer
Psychopharmacology|March 8, 2017
A short history of the 5-HT<sub>2C</sub> receptor: from the choroid plexus to depression, obesity and addiction treatmentJose M Palacios, Angel Pazos, Daniel Hoyer
British Journal of Clinical Pharmacology|November 23, 2019
Hypnotics with novel modes of actionDaniel Hoyer, Andrew Allen, Laura H Jacobson
Biological Psychiatry|July 5, 2003
Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodentsJohn F Cryan, Daniel Hoyer, Athina Markou
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 22, 2020
SMAD4 protein is decreased in the dorsolateral prefrontal and anterior cingulate cortices in schizophreniaAndrew S Gibbons, Daniel Hoyer, Brian Dean
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 5, 2003
Functional characterisation of the putative somatostatin sst2 receptor antagonist CYN 154806Caroline Nunn, Philippe Schoeffter, Daniel Langenegger, et al.
Pharmacology & Therapeutics|September 27, 2005
Interfering with the brain: use of RNA interference for understanding the pathophysiology of psychiatric and neurological disordersDeepak R Thakker, Daniel Hoyer, John F Cryan
Pageof 16

Showing results (11-20 of 151) with videos related to

Sort By:
Pageof 16
Drug Discovery Today. Therapeutic Strategies|April 15, 2020
RNA interference as a therapeutic strategy for treating CNS disordersDaniel Hoyer, Kumlesh K Dev
Science (New York, N.Y.)|February 24, 2022
Losing sleep with ageLaura H Jacobson, Daniel Hoyer
Neuropeptides|November 13, 2013
Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?Daniel Hoyer, Laura H Jacobson
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 17, 2003
Native somatostatin sst2 and sst5 receptors functionally coupled to Gi/o-protein, but not to the serum response element in AtT-20 mouse tumour corticotrophsDavide Cervia, Dominique Fehlmann, Daniel Hoyer
Psychopharmacology|March 8, 2017
A short history of the 5-HT<sub>2C</sub> receptor: from the choroid plexus to depression, obesity and addiction treatmentJose M Palacios, Angel Pazos, Daniel Hoyer
British Journal of Clinical Pharmacology|November 23, 2019
Hypnotics with novel modes of actionDaniel Hoyer, Andrew Allen, Laura H Jacobson
Biological Psychiatry|July 5, 2003
Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodentsJohn F Cryan, Daniel Hoyer, Athina Markou
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 22, 2020
SMAD4 protein is decreased in the dorsolateral prefrontal and anterior cingulate cortices in schizophreniaAndrew S Gibbons, Daniel Hoyer, Brian Dean
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 5, 2003
Functional characterisation of the putative somatostatin sst2 receptor antagonist CYN 154806Caroline Nunn, Philippe Schoeffter, Daniel Langenegger, et al.
Pharmacology & Therapeutics|September 27, 2005
Interfering with the brain: use of RNA interference for understanding the pathophysiology of psychiatric and neurological disordersDeepak R Thakker, Daniel Hoyer, John F Cryan
Pageof 16